Leadership Transition at UVM Health Network
September 18, 2025 - 23:02
In a significant leadership change, the UVM Health Network has announced that Sunny Eappen will be stepping down from his role. As the network prepares for this transition, Steven Leffler, the current leader of the University of Vermont Medical Center, has been appointed as the interim president and CEO.
Leffler brings a wealth of experience to the position, having played a pivotal role in the operations of the medical center. His leadership is expected to ensure continuity and stability during this period of change. The network is committed to maintaining its high standards of care and support for the community while navigating this transition.
As the health network moves forward, stakeholders and staff are optimistic about Leffler’s ability to guide the organization through this period. The focus remains on delivering exceptional healthcare services and addressing the evolving needs of patients and families in the region.
MORE NEWS
May 9, 2026 - 22:43
College of Pharmacy & Health Sciences confers 206 degrees - NewsThe Campbell University College of Pharmacy & Health Sciences held its spring commencement ceremony to honor the achievements of the Class of 2026. A total of 206 degrees were conferred during the...
May 9, 2026 - 02:40
California Becomes First State to Offer Free Diapers for Every NewbornCalifornia is set to launch a first-of-its-kind program that will provide free diapers to every newborn in the state. The initiative, which makes California the first state in the country to offer...
May 8, 2026 - 11:45
Maryland ranked high among states for public health preparedness, but could be doing moreMaryland continues to rank among the top states in the nation for its ability to handle public health emergencies, according to a recent analysis by a national health policy organization. The state...
May 7, 2026 - 18:47
Healthy Returns: First Ozempic generics in Canada will be a test case for Novo NordiskThe arrival of the first generic versions of semaglutide in Canada is being watched closely as a potential turning point for Novo Nordisk`s dominance in the global weight-loss and diabetes market....